149 related articles for article (PubMed ID: 34147901)
1. The nonreceptor protein tyrosine kinase Src participates in every step of cancer-induced bone pain.
Li Y; Bao Y; Zheng H; Qin Y; Hua B
Biomed Pharmacother; 2021 Sep; 141():111822. PubMed ID: 34147901
[TBL] [Abstract][Full Text] [Related]
2. Cancer-nerve interplay in cancer progression and cancer-induced bone pain.
Yoneda T; Hiasa M; Okui T; Hata K
J Bone Miner Metab; 2023 May; 41(3):415-427. PubMed ID: 36715764
[TBL] [Abstract][Full Text] [Related]
3. The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.
Appel CK; Gallego-Pedersen S; Andersen L; Blancheflor Kristensen S; Ding M; Falk S; Sayilekshmy M; Gabel-Jensen C; Heegaard AM
Sci Rep; 2017 Jul; 7(1):4792. PubMed ID: 28684771
[TBL] [Abstract][Full Text] [Related]
4. SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer.
Saad F; Lipton A
Cancer Treat Rev; 2010 Apr; 36(2):177-84. PubMed ID: 20015594
[TBL] [Abstract][Full Text] [Related]
5. Bone Metastasis Pain, from the Bench to the Bedside.
Aielli F; Ponzetti M; Rucci N
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30641973
[TBL] [Abstract][Full Text] [Related]
6. Cancer induced bone pain: current management and future perspectives.
Kapoor R; Saxena AK; Vasudev P; Sundriyal D; Kumar A
Med Oncol; 2021 Sep; 38(11):134. PubMed ID: 34581894
[TBL] [Abstract][Full Text] [Related]
7. miR-300 mitigates cancer-induced bone pain through targeting HMGB1 in rat models.
Liu C; Yang J; Liu H; Xia T; Zhang F
Genes Genomics; 2020 Mar; 42(3):309-316. PubMed ID: 31872385
[TBL] [Abstract][Full Text] [Related]
8. SAP102 contributes to hyperalgesia formation in the cancer induced bone pain rat model by anchoring NMDA receptors.
He QL; Deng HS; Xu LS; Zhu JJ; Ni HD; Wang TT; Wang YG; Shen H; Pan H; Yao M
Neurosci Lett; 2020 Jan; 714():134595. PubMed ID: 31682872
[TBL] [Abstract][Full Text] [Related]
9. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.
Myoui A; Nishimura R; Williams PJ; Hiraga T; Tamura D; Michigami T; Mundy GR; Yoneda T
Cancer Res; 2003 Aug; 63(16):5028-33. PubMed ID: 12941830
[TBL] [Abstract][Full Text] [Related]
10. Spinal SET7/9 may contribute to the maintenance of cancer-induced bone pain in mice.
Hang LH; Xu ZK; Wei SY; Shu WW; Luo H; Chen J
Clin Exp Pharmacol Physiol; 2017 Oct; 44(10):1001-1007. PubMed ID: 28557056
[TBL] [Abstract][Full Text] [Related]
11. Astrocyte activation in the periaqueductal gray promotes descending facilitation to cancer-induced bone pain through the JNK MAPK signaling pathway.
Ni HD; Xu LS; Wang Y; Li H; An K; Liu M; Liu Q; Deng H; He Q; Huang B; Fang J; Yao M
Mol Pain; 2019; 15():1744806919831909. PubMed ID: 30700204
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy.
Rucci N; Recchia I; Angelucci A; Alamanou M; Del Fattore A; Fortunati D; Susa M; Fabbro D; Bologna M; Teti A
J Pharmacol Exp Ther; 2006 Jul; 318(1):161-72. PubMed ID: 16627750
[TBL] [Abstract][Full Text] [Related]
13. The Role of Spinal GABAB Receptors in Cancer-Induced Bone Pain in Rats.
Zhou YQ; Chen SP; Liu DQ; Manyande A; Zhang W; Yang SB; Xiong BR; Fu QC; Song ZP; Rittner H; Ye DW; Tian YK
J Pain; 2017 Aug; 18(8):933-946. PubMed ID: 28323246
[TBL] [Abstract][Full Text] [Related]
14. Proteomic profiling reveals Arl6ip-1 as a candidate target in cancer-induced bone pain rat model after oxycodone treatment.
Deng HS; Xu LS; Ni HD; Wang TT; Liu MJ; Yang MX; Shen H; Pan H; Yao M
Neurosci Lett; 2019 Apr; 699():151-159. PubMed ID: 30708128
[TBL] [Abstract][Full Text] [Related]
15. Neurophysiological mechanisms of cancer-induced bone pain.
Zheng XQ; Wu YH; Huang JF; Wu AM
J Adv Res; 2022 Jan; 35():117-127. PubMed ID: 35003797
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain.
Forte BL; Slosky LM; Zhang H; Arnold MR; Staatz WD; Hay M; Largent-Milnes TM; Vanderah TW
Pain; 2016 Dec; 157(12):2709-2721. PubMed ID: 27541850
[TBL] [Abstract][Full Text] [Related]
17. Loss of Androgen-Regulated MicroRNA 1 Activates SRC and Promotes Prostate Cancer Bone Metastasis.
Liu YN; Yin J; Barrett B; Sheppard-Tillman H; Li D; Casey OM; Fang L; Hynes PG; Ameri AH; Kelly K
Mol Cell Biol; 2015 Jun; 35(11):1940-51. PubMed ID: 25802280
[TBL] [Abstract][Full Text] [Related]
18. Src as a therapeutic target in men with prostate cancer and bone metastases.
Saad F
BJU Int; 2009 Feb; 103(4):434-40. PubMed ID: 19154462
[TBL] [Abstract][Full Text] [Related]
19. Identification of lncRNA and mRNA expression profiles in dorsal root ganglion in rats with cancer-induced bone pain.
Wei J; Dou Q; Ba F; Xu GY; Jiang GQ
Biochem Biophys Res Commun; 2021 Oct; 572():98-104. PubMed ID: 34364296
[TBL] [Abstract][Full Text] [Related]
20. JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1.
Wang ZL; Du TT; Zhang RG
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):88-94. PubMed ID: 26838746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
